✦ LIBER ✦

Improved functional cardiac MR imaging using the intravascular contrast agent CLARISCAN™

✍ Scribed by I. Paetsch; H. Thiele; B. Schnackenburg; A. Bornstedt; A. Müller-York; J. Schwab; E. Fleck; E. Nagel

Book ID: 111550579
Publisher: Springer
Year: 2003
Tongue: English
Weight: 215 KB
Volume: 19
Category: Article
ISSN: 1569-5794
DOI: 10.1023/a:1025432415983

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The intravascular contrast agent Clarisc

The intravascular contrast agent Clariscan™ (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease

✍ Christoph Klein; Eike Nagel; Bernhard Schnackenburg; Axel Bornstedt; Simon Schal 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 252 KB

Deep venous thrombosis and consecutive p

Deep venous thrombosis and consecutive pulmonary embolism as the first sign of an ovarian cancer: MR angiography using an intravascular contrast agent (CLARISCAN)

✍ Joern J.W. Sandstede; Ulrich Krause; Thomas Pabst; Volker Hoffmann; Heiko Braun; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

The intravascular contrast agent Clarisc

The intravascular contrast agent Clariscanâ¢ (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease

✍ Klein, C 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 252 KB

Functional cardiac MR imaging with stead

Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents

✍ Holger Thiele; Eike Nagel; Ingo Paetsch; Bernhard Schnackenburg; Axel Bornstedt; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

## Abstract Contrast between blood and myocardium in standard turbo gradient echo MR techniques (TFE) used routinely in clinical practice is mainly caused by unsaturated inflowing blood. Steady‐state free precession (SSFP) has excellent contrast even in the absence of inflow effects. In 45 subjects

Initial experience with the intravascula

Initial experience with the intravascular contrast agent NC100150-injection (Clariscan®) for breath-hold and navigator-gated magnetic resonance coronary artery imaging

✍ Nicholas H. Bunce; Jennifer Keegan; Peter D. Gatehouse; James C.C. Moon; David N 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

## Abstract ## Purpose To examine magnetic resonance coronary artery imaging after NC100150‐Injection. ## Materials and Methods Breath‐hold and navigator‐gated images were acquired in five patients. ## Results Breath‐hold image quality, coronary artery‐fat SDNR, and coronary artery SNR improve

Improvement of image quality of non-inva

Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan™ (NC100150 injection) in patients with coronary artery disease

✍ Christoph Klein; Simon Schalla; Bernhard Schnackenburg; Axel Bornstedt; Volker H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 803 KB

## Abstract ## Purpose To assess the feasibility of Clariscan™, an intravascular contrast agent, for free breathing, navigator assisted, high resolution, three‐dimensional‐magnetic resonance coronary angiography (MRCA) in patients, as extracellular contrast agents are unfavorable for the improveme